SCHEMBL7388035

SCHEMBL7388035

CCOC(=O)CN(c1ccc2[nH]c(CCc3ccc(C#N)cc3)nc2c1CC)S(=O)(=O)c1cccc2cccnc12

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
GAA P10253 1/20 0.38
ALDH1A1 P00352 6/20 0.37
MAPT P10636 2/20 0.36
F2 P00734 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
PGGT1B P53609 1/20 0.35
CHEK1 O14757 1/20 0.35
TP53 P04637 3/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
FABP1 P07148 1/20 0.33
GLO1 Q04760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7392529 0.94 TSHR (0.40) TSHRGAAALDH1A1MAPTF2
SCHEMBL7393575 0.85 F2 (0.43) TSHRALDH1A1MAPTF2FNTA
SCHEMBL7389790 0.80 CHEK1 (0.37) TSHRALDH1A1MAPTCHEK1KDM4E
SCHEMBL7385266 0.76 F2 (0.39) TSHRGAAALDH1A1MAPTF2
SCHEMBL6634546 0.76 F2 (0.47) TSHRGAAALDH1A1MAPTF2
SCHEMBL6635031 0.75 F2 (0.45) TSHRGAAALDH1A1MAPTF2
SCHEMBL7393934 0.75 F2 (0.49) ALDH1A1MAPTF2TP53POLB
SCHEMBL6635727 0.75 F2 (0.49) TSHRGAAALDH1A1MAPTF2
SCHEMBL6633463 0.75 F2 (0.45) TSHRGAAALDH1A1MAPTF2
SCHEMBL6637732 0.74 F2 (0.43) TSHRGAAALDH1A1MAPTF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed